Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis With Prior exposure to JAK1/2 Inhibitors

The impact of JAK1/2 inhibitor therapy prior to allogeneic hematopoietic cell transplantation (HCT) has not been studied in a large cohort in myelofibrosis (MF). In this retrospective multicenter study, we analyzed outcomes of patients who underwent HCT for MF with prior exposure to JAK1/2 inhibitor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Shanavas, Mohamed, Popat, Uday, Michaelis, Laura C, Fauble, Veena, McLornan, Donal, Klisovic, Rebecca, Mascarenhas, John, Tamari, Roni, Arcasoy, Murat O, Davies, James, Gergis, Usama, Ukaegbu, Oluchi C, Kamble, Rammurti T, Storring, John M, Majhail, Navneet S, Romee, Rizwan, Verstovsek, Srdan, Pagliuca, Antonio, Vasu, Sumithira, Ernst, Brenda, Atenafu, Eshetu G, Hanif, Ahmad, Champlin, Richard, Hari, Paremeswaran, Gupta, Vikas
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030817/
https://ncbi.nlm.nih.gov/pubmed/26493563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky